You are here: Annual Meeting / Past Events / 2013 / Programme
Saturday, 16.12.2017
Meeting sponsors

 

All sponsor grants are unrestricted.

Program

THURSDAY, MAY 2ND, 2013
PRE-MEETING EVENT

13.00-21.00 EDUCATIONAL WORKSHOP: UPDATE ON NEUROPSYCHOPHARMACOLOGY
Brian Leonard (Galway, Ireland) & Gregers Wegener (Aarhus, Denmark) 

FRIDAY, MAY 3th, 2013

09.00- REGISTRATION OPENS

10.00-10.05 PRESIDENT´S WELCOME

10.05-11.00  OPENING LECTURE
Antipsychotics: Options for individualized therapy
Shitij Kapur (London, United Kingdom)

11.00-12.30   SYMPOSIUM
Side effects management in psychiatry

Sexual side effects of antidepressant drugs
David Baldwin (Southampton, UK)

Metabolic side effects of antipsychotics
Vidar M. Steen (Bergen, Norway)

Lithium: side effect management today
Per Vestergaard (Aarhus, Denmark)

12.30-13.15  LUNCH (from Meyers Kitchen)

13.15-14.45 SYMPOSIUM
Post Traumatic Stress Disorder

PTSD in Military cohorts: what have we learnt?
Eric Vermetten (Utrecht, The Netherlands)

What is the stressor in PTSD? A memory based model. 
Dorthe Berntsen (Aarhus, Denmark)

Prevention of traumatic memory consolidation as a therapeutic tool in PTSD
Joseph Zohar (Jerusalem, Israel)

14.45-15.15  COFFEE BREAK

15.15-16.00 SCNP LECTURE
Neurotransmitter approaches to the treatment of depression
David Nutt (London, UK)

16.00-17.30  SCNP YOUNG SCIENTIST SYMPOSIUM
Speakers to be announced (based on competition)

17.30-19.00 POSTER SESSION.
Refreshments

19.30-     SCNP 2013 RECEPTION IN POSTER AND EXHIBITION AREA.
Standing dinner with food and wine from Meyers Kitchen

SATURDAY, MAY 4th, 2013

08.00-09.45  SYMPOSIUM
Treatment targets in Neuropsychiatry

The role of the Serotonin transporter in psychiatric disorders
Klaus-Peter Lesch (Würzburg, Germany)

The role of P11 in depression
Per Svenningsson (Stockholm, Sweden)

Epigenetic mechanisms and targets in depression
Sâmia Joca (São Paulo, Brazil)

09.45-10.15  COFFEE BREAK

10.15-11.45   SYMPOSIUM
Somatic comorbidity in psychiatry

Overlapping genetic profiles of Schizophrenia and cardiovascular risk factors 
Ole A. Andreassen (Oslo, Norway)

Pain and psychiatric disorders
Lise Gormsen (Aarhus, Denmark)

Is there connection between heart disease and anxiety?
Christine Bringager (Oslo, Norway)

11.45-13.15   SYMPOSIUM 
Optimising treatment in psychiatry. Where are we now? 

The use pharmacogenetics to guide psychiatric treatment
Dan Rujescu (Halle, Germany)

The biology of psychosis and treatment resistance: Clinical implications
Oliver Howes (London, United Kingdom)

Major cognitive disorders – drug development based on disease mechanisms – does it work?
Lars Nilsson (Oslo, Norway)

13.15-14.00  LUNCH (from Meyers Kitchen)

14.00-15.30  DSBP SYMPOSIUM
Psychophysiology of sleep disturbances. From bench to bedside

Chronic insomnia and hyperarousal - state of the art
Dieter Riemann (Freiburg, Germany)

Co-morbid insomnia
Poul Jennum (Copenhagen, Denmark)

Insomnia in psychotic disorders
Lone Baandrup (Copenhagen, Denmark)

15.30-16.00  COFFEE BREAK

16.00-17.30  SYMPOSIUM
ADHD treatment Update

Pharmacological treatment of inmates with ADHD, a randomized controlled study and follow-up
Martin Grann (Stockholm, Sweden)

Pharmacological treatment of ADHD with amphetamine dependence
Maija Konstenius (Stockholm, Sweden)

Lisdexamphetamine: a prodrug principle for the treatment of ADHD
Kevin Kjernisted (Vancouver, Canada)

17.30             CONCLUSION OF MEETING